1
|
Lu X, Deng X, Kong F, Hai W, Luo Q. Construction and Preliminary Evaluation of Two 18F-Labeled Radiopharmaceuticals for Myocardial Perfusion Imaging. Anal Chem 2024; 96:11725-11733. [PMID: 38975941 DOI: 10.1021/acs.analchem.4c00709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/09/2024]
Abstract
AIMS PET myocardial perfusion imaging (MPI) is the gold standard for the noninvasive diagnosis of ischemic myocardial. Construction of 18F-labeled PET MPI probe showed benefits to reduce the imaging cost, and enhance the image quality and patient-friendliness. METHODS Two 18F-labeled MPI probes (18F-BoMPI) were developed. Detailed in vitro/vivo evaluation including photophysical properties, in vitro stability, myocardial cell uptake kinetics and mechanisms, cytotoxicity and IC50, biodistribution and plasma clearance curve were investigated. Resting and stressing myocardial perfusion PET imaging were performed in healthy and myocardial ischemic mice. RESULTS 18F-BoMPI could be quickly labeled and easily postprocessed, and demonstrated excellent in vitro stability. Cell assays indicated that 18F-BoMPI exhibited mitochondria-targeting but potential-independent myocardial uptake. In vivo evaluation revealed the effective myocardial uptake and rapid background clearance. PET MPI confirmed effective probe accumulation in the healthy heart, but rapidly clearance in the background, making heart clearly delineated in the images. Ischemic myocardial could be clearly distinguished as the region of radioactivity sparsity in PET MPI. CONCLUSION The 18F-labeled probes showed great potentials to reduce the practicability threshold of PET MPI.
Collapse
Affiliation(s)
- Xinmiao Lu
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200235, China
| | - Xiaohui Deng
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
| | - Fei Kong
- School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
| | - Wangxi Hai
- Department of Nuclear Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Quanyong Luo
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200235, China
| |
Collapse
|
2
|
Ren C, Pan Q, Fu C, Wang P, Zheng Z, Hsu B, Huo L. Phase I, first-in-human study of XTR004, a novel 18F-labeled tracer for myocardial perfusion PET: Biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest. J Nucl Cardiol 2024; 34:101823. [PMID: 38360262 DOI: 10.1016/j.nuclcard.2024.101823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 02/03/2024] [Accepted: 02/06/2024] [Indexed: 02/17/2024]
Abstract
OBJECTIVES This study assessed the imaging characteristics, pharmacokinetics and safety of XTR004, a novel 18F-labeled Positron Emission Tomography (PET) myocardial perfusion imaging tracer, after a single injection at rest in humans. METHODS Eleven healthy subjects (eight men and three women) received intravenous XTR004 (239-290 megabecquerel [MBq]). Safety profiles were monitored on the dosing day and three follow-up visits. Multiple whole-body PET scans were conducted over 4.7 h to evaluate biodistribution and radiation dosimetry. Blood and urine samples collected for 7.25 h were metabolically corrected to characterize pharmacokinetics. RESULTS In the first 0-12 min PET images of ten subjects, liver (26.81 ± 4.01), kidney (11.43 ± 2.49), lung (6.75 ± 1.76), myocardium (4.72 ± 0.67) and spleen (3.1 ± 0.84) exhibited the highest percentage of the injected dose (%ID). Myocardial uptake of XTR004 in the myocardium initially reached 4.72 %ID and 7.06 g/mL, and negligibly changed within an hour (Δ: 7.20%, 5.95%). The metabolically corrected plasma peaked at 2.5 min (0.0013896 %ID/g) and halved at 45.2 min. Whole-body effective dose was 0.0165 millisievert (mSv)/MBq. Cumulative urine excretion was 8.18%. Treatment-related adverse events occurred in seven out of eleven subjects (63.6%), but no severe adverse event was reported. CONCLUSIONS XTR004 demonstrated a favorable safety profile, rapid, high, and stable myocardial uptake and excellent potential for PET myocardial perfusion imaging (MPI). Further exploration of XTR004 PET MPI for detecting myocardial ischemia is warranted.
Collapse
Affiliation(s)
- Chao Ren
- Nuclear Medicine Department, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
| | - Qingqing Pan
- Nuclear Medicine Department, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
| | - Chao Fu
- Nuclear Medicine Department, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
| | - Peipei Wang
- Nuclear Medicine Department, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
| | - Zhiquan Zheng
- Medical Department, Sinotau Pharmaceutical Group, Beijing, China
| | - Bailing Hsu
- Nuclear Science and Engineering Institute, University of Missouri-Columbia, Columbia, MO, USA.
| | - Li Huo
- Nuclear Medicine Department, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
| |
Collapse
|
4
|
Abstract
PET-based cardiac nuclear imaging plays a large role in the management of ischemic heart disease. Compared with conventional single-photon emission CT myocardial perfusion imaging, PET provides superior accuracy in diagnosis of coronary artery disease and, with the incorporation of myocardial blood flow and coronary flow reserve, adds value in assessing prognosis for established coronary and microvascular disease. This review describes these and other uses of PET in ischemic heart disease, including assessing myocardial viability in ischemic cardiomyopathy. Developments in novel PET flow tracers and molecular imaging tools to assess atherosclerotic plaque vulnerability, vascular calcification, and vascular remodeling also are described.
Collapse
Affiliation(s)
- Kevin Chen
- Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
| | - Edward J Miller
- Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
| | - Mehran M Sadeghi
- Section of Cardiovascular Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA; Veterans Affairs Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, USA.
| |
Collapse
|
7
|
Kim JW, Seo S, Kim HS, Kim DY, Lee HY, Kang KW, Lee DS, Bom HS, Min JJ, Lee JS. Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP. Ann Nucl Med 2017; 31:469-479. [PMID: 28444503 PMCID: PMC5486518 DOI: 10.1007/s12149-017-1171-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2017] [Accepted: 04/16/2017] [Indexed: 02/05/2023]
Abstract
Objective (18F-fluoropentyl)triphenylphosphonium salt (18F-FPTP) is a new promising myocardial PET imaging tracer. It shows high accumulation in cardiomyocytes and rapid clearance from liver. We performed compartmental analysis of 18F-FPTP PET images in rat and evaluated two linear analyses: linear least-squares (LLS) and a basis function method (BFM) for generating parametric images. The minimum dynamic scan duration for kinetic analysis was also investigated and computer simulation undertaken. Methods 18F-FPTP dynamic PET (18 min) and CT images were acquired from rats with myocardial infarction (MI) (n = 12). Regions of interest (ROIs) were on the left ventricle, normal myocardium, and MI region. Two-compartment (K1 and k2; 2C2P) and three-compartment (K1–k3; 3C3P) models with irreversible uptake were compared for goodness-of-fit. Partial volume and spillover correction terms (Va and α = 1 − Va) were also incorporated. LLS and BFM were applied to ROI- and voxel-based kinetic parameter estimations. Results were compared with the standard ROI-based nonlinear least-squares (NLS) results of the corresponding compartment model. A simulation explored statistical properties of the estimation methods. Results The 2C2P model was most suitable for describing 18F-FPTP kinetics. Average K1, k2, and Va values were, respectively, 6.8 (ml/min/g), 1.1 (min−1), and 0.44 in normal myocardium and 1.4 (ml/min/g), 1.1 (min−1), and 0.32, in MI tissue. Ten minutes of data was sufficient for the estimation. LLS and BFM estimations correlated well with NLS values for the ROI level (K1: y = 1.06x + 0.13, r2 = 0.96 and y = 1.13x + 0.08, r2 = 0.97) and voxel level (K1: y = 1.22x − 0.30, r2 = 0.90 and y = 1.26x + 0.00, r2 = 0.92). Regional distribution of kinetic parametric images (αK1, K1, k2, Va) was physiologically relevant. LLS and BFM showed more robust characteristics than NLS in the simulation. Conclusions Fast kinetics and highly specific uptake of 18F-FPTP by myocardium enabled quantitative analysis with the 2C2P model using only the initial 10 min of data. LLS and BFM were feasible for estimating voxel-wise parameters. These two methods will be useful for quantitative evaluation of 18F-FPTP distribution in myocardium and in further studies with different conditions, disease models, and species. Electronic supplementary material The online version of this article (doi:10.1007/s12149-017-1171-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Ji Who Kim
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Seongho Seo
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Hyeon Sik Kim
- Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Dong-Yeon Kim
- Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Ho-Young Lee
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Keon Wook Kang
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Biomedical Sciences, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Dong Soo Lee
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea.,Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 1 Gwanak-ro, Gwanak-Gu, Seoul, 08826, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Hee-Seung Bom
- Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Jung-Joon Min
- Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea.,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea
| | - Jae Sung Lee
- Department of Nuclear Medicine, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea. .,Department of Biomedical Sciences, Seoul National University College of Medicine, Daehak-ro 101, Chongnogu, Seoul, 03080, Korea. .,Department of Cardiology, Chonnam National University Hwasun Hospital, 160 Ilsimri, Hwasun, 519-809, Jeonnam, Korea.
| |
Collapse
|
9
|
Chansaenpak K, Wang H, Wang M, Giglio B, Ma X, Yuan H, Hu S, Wu Z, Li Z. Synthesis and Evaluation of [(18) F]-Ammonium BODIPY Dyes as Potential Positron Emission Tomography Agents for Myocardial Perfusion Imaging. Chemistry 2016; 22:12122-9. [PMID: 27405398 DOI: 10.1002/chem.201601972] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2016] [Revised: 06/06/2016] [Indexed: 01/06/2023]
Abstract
Recently, we demonstrated the potential of a [(18) F]-trimethylammonium BODIPY dye for cardiac imaging. This is the first example of the use of the [(18) F]-ammonium BODIPY dye for positron emission tomography (PET) myocardial perfusion imaging (MPI). In this report, we extend our study to other ammonium BODIPY dyes with different nitrogen substituents. These novel ammonium BODIPY dyes were successfully prepared and radiolabeled by the SnCl4 -assisted (18) F-(19) F isotopic exchange method. The microPET results and the biodistribution data reveal that nitrogen substituent changes have a significant effect on the in vivo and pharmacological properties of the tracers. Of the novel [(18) F]-ammonium BODIPY dyes prepared in this work, the [(18) F]-dimethylethylammonium BODIPY is superior in terms of myocardium uptake and PET imaging contrast. These results support our hypothesis that the ammonium BODIPY dyes have a great potential for use as PET/optical dual-modality MPI probes.
Collapse
Affiliation(s)
- Kantapat Chansaenpak
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Hui Wang
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Mengzhe Wang
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Benjamin Giglio
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Xiaofeng Ma
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Hong Yuan
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| | - Shuo Hu
- PET Center of Xiangya Hospital, Central South University, Changsha, 410008, China.
| | - Zhanhong Wu
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA.
| | - Zibo Li
- Biomedical Research Imaging Center, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, 27514, USA
| |
Collapse
|